Table 2.
EBS (n=97) | PTBD (n=48) | p | |
---|---|---|---|
*Clinical success (%, ratio) | 52.6% (50/95) | 67.4% (31/46) | 0.097 |
TBIL decrease (µmol/L) | 36.70 | 66.90 | 0.006 |
Complication (%, ratio) | 39.2%(38/97) | 39.6% (19/48) | 0.962 |
Cholangitis (%, ratio) | 27.8% (27/97) | 29.2% (14/48) | 0.867 |
Hemorrhage (%, ratio) | 3.1% (3/97) | 2.1% (1/48) | 1.000 |
Notes: *Postprocedure TBIL was missing in 2 cases in each group.